(NYSE:FDS),(NASDAQ:FDS), NORWALK, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) — FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.10 per share. The cash dividend will be paid on December 18, 2025, to holders of record […]
(NYSE MKT:AMS), Call Scheduled for November 13th at 1:00 PM ET SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care services segments, today announced that
(NASDAQ:NMRA), Announced class-leading data from diet-induced obesity (DIO) mouse model with NMRA-215, a potentially best-in-class, highly brain-penetrant, oral NLRP3 inhibitor, and expect to initiate Phase 1 study in first quarter of 2026 Advancing Phase 1 studies with two potentially best-in-class positive allosteric modulators (PAMs), NMRA-861 and NMRA-898, with comprehensive franchise update expected by mid-2026 On-track
(NASDAQ:PBM), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a major clinical milestone with multiple patients successfully dosed in its ongoing Phase IIb clinical trial evaluating nature-derived psilocybin, in
(NASDAQ:TNXP), CHATHAM, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced that Seth Lederman, M.D., Tonix's Chief Executive Officer, will be presenting at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 10:00 AM ET. Investors interested in
(Other OTC:OTCM),(OTC US:OTCM),(AUST:SS1.AX),(Other OTC:SSLVF), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced SUN SILVER LTD. (ASX: SS1; OTCQX: SSLVF), an Australian exploration company, has qualified to trade on the OTCQX(R) Best Market. SUN SILVER LTD. upgraded
(NASDAQ:MRX), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Marex Group plc ('Marex' or the 'Group'; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported financial results for the third quarter ('Q3 2025'). Ian Lowitt, Group Chief
Americold Announces Third Quarter 2025 Results GlobeNewswire November 06, 2025 Total Revenue Increased 2% SequentiallyDelivered $0.35 AFFO Per ShareReiterated 2025 Full-Year Outlook ATLANTA, GA, Nov. 06, 2025 (GLOBE NEWSWIRE) — Americold Realty Trust, Inc. (NYSE: COLD) (the “Company”), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition
(NASDAQ:IMCR), Immunocore reports third quarter financial results and provides a business update KIMMTRAK(R) (tebentafusp-tebn) net revenues of $103.7 million in 3Q 2025, growing by 29% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 160 mcg selected as the go-forward dose for brenetafusp in Phase 3 PRISM-MEL-301 trial, following Independent Data
Electrokare Launches Groundbreaking Real-Time Electrolyte Tracking Platform to Power the Modern Performance Athlete Blending real-time electrolyte tracking with intelligent recovery insights, Electrokare helps athletes of all kinds unlock their potential, prevent burnout, and perform at their peak. GlobeNewswire November 06, 2025 Chattanooga, Tennessee, Nov. 06, 2025 (GLOBE NEWSWIRE) — Electrokare, the performance technology company redefining